Mathematical modelling of the spatio-temporal response of cytotoxic T-lymphocytes to a solid tumour.

In this paper a mathematical model describing the growth of a solid tumour in the presence of an immune system response is presented. In particular, attention is focused upon the attack of tumour cells by so-called tumour-infiltrating cytotoxic lymphocytes (TICLs), in a small, multicellular tumour, without necrosis and at some stage prior to (tumour-induced) angiogenesis. At this stage the immune cells and the tumour cells are considered to be in a state of dynamic equilibrium--cancer dormancy--a phenomenon which has been observed in primary tumours, micrometastases and residual disease after ablation of the primary tumour. Nonetheless, the precise biochemical and cellular mechanisms by which TICLs control cancer dormancy are still poorly understood from a biological and immunological point of view. Therefore we focus on the analysis of the spatio-temporal dynamics of tumour cells, immune cells and chemokines in an immunogenic tumour. The lymphocytes are assumed to migrate into the growing solid tumour and interact with the tumour cells in such a way that lymphocyte-tumour cell complexes are formed. These complexes result in either the death of the tumour cells (the normal situation) or the inactivation (sometimes even the death) of the lymphocytes. The migration of the TICLs is determined by a combination of random motility and chemotaxis in response to the presence of chemokines. The resulting system of four nonlinear partial differential equations (TICLs, tumour cells, complexes and chemokines) is analysed and numerical simulations are presented. We consider two different tumour geometries--multi-layered cell growth and multi-cellular spheroid growth. The numerical simulations demonstrate the existence of cell distributions that are quasi-stationary in time and heterogeneous in space. A linear stability analysis of the underlying (spatially homogeneous) ordinary differential equation (ODE) kinetics coupled with a numerical investigation of the ODE system reveals the existence of a stable limit cycle. This is verified further when a subsequent bifurcation analysis is undertaken using a numerical continuation package. These results then explain the complex heterogeneous spatio-temporal dynamics observed in the partial differential equation (PDE) system. Our approach may lead to a deeper understanding of the phenomenon of cancer dormancy and may be helpful in the future development of more effective anti-cancer vaccines.

[1]  M. Retsky,et al.  Prospective computerized simulation of breast cancer: comparison of computer predictions with nine sets of biological and clinical data. , 1987, Cancer research.

[2]  Jonathan A. Sherratt,et al.  Oscillations and chaos behind predator–prey invasion: mathematical artifact or ecological reality? , 1997 .

[3]  L. Chen,et al.  Immune regulation of the L5178Y murine tumor-dormant state. II. Interferon-gamma requires tumor necrosis factor to restrain tumor cell growth in peritoneal cell cultures from tumor-dormant mice. , 1987, Journal of immunology.

[4]  James P. Freyer,et al.  Tumor growthin vivo and as multicellular spheroids compared by mathematical models , 1994, Bulletin of mathematical biology.

[5]  R. Demicheli,et al.  Tumour dormancy: findings and hypotheses from clinical research on breast cancer. , 2001, Seminars in cancer biology.

[6]  H. Kiss,et al.  The Transfer of Interleukin‐8 Across the Human Placenta Perfused In Vitro , 1996, Obstetrics and gynecology.

[7]  V. Kuznetsov A mathematical model for the interaction between cytotoxic T lymphocytes and tumour cells. Analysis of the growth, stabilization, and regression of a B-cell lymphoma in mice chimeric with respect to the major histocompatibility complex. , 1991, Biomedical science.

[8]  J. Xiang,et al.  Lymphotactin Expression by Engineered Myeloma Cells Drives Tumor Regression: Mediation by CD4+ and CD8+ T Cells and Neutrophils Expressing XCR1 Receptor1 , 2001, The Journal of Immunology.

[9]  V. P. Zhivoglyadov,et al.  Kinetic approach and estimation of the parameters of cellular interaction between the immunity system and a tumor. , 1993, Archivum immunologiae et therapiae experimentalis.

[10]  D. Drasdo,et al.  Individual-based approaches to birth and death in avascu1ar tumors , 2003 .

[11]  P. Friedl,et al.  T lymphocyte locomotion in a three-dimensional collagen matrix. Expression and function of cell adhesion molecules. , 1995, Journal of immunology.

[12]  T. Whiteside,et al.  T cell recognition of human tumors: implications for molecular immunotherapy of cancer. , 1993, Clinical immunology and immunopathology.

[13]  G. Bard Ermentrout,et al.  Transition fronts and localized structures in bistable reaction-diffusion equations , 1997 .

[14]  J. Uhr,et al.  Cancer dormancy: studies of the murine BCL1 lymphoma. , 1991, Cancer research.

[15]  J. Aguirre Ghiso Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo , 2002, Oncogene.

[16]  M. Nowak,et al.  Virus dynamics: Mathematical principles of immunology and virology , 2001 .

[17]  Ying Wang,et al.  IL-8 Reduced Tumorigenicity of Human Ovarian Cancer In Vivo Due to Neutrophil Infiltration1 , 2000, The Journal of Immunology.

[18]  R. Puri,et al.  Interleukin-4 and cancer therapy. , 1993, Cancer investigation.

[19]  F. Shanahan,et al.  The Fas counterattack: cancer as a site of immune privilege. , 1999, Immunology today.

[20]  John A. Adam,et al.  The dynamics of growth-factor-modified immune response to cancer growth: One dimensional models , 1993 .

[21]  N. Breslow,et al.  Latent carcinoma of prostate at autopsy in seven areas. Collaborative study organized by the International Agency for Research on Cancer, Lyons, France , 1977, International journal of cancer.

[22]  M. Herlyn,et al.  Insulin-like growth factor-I-induced migration of melanoma cells is mediated by interleukin-8 induction. , 2002, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[23]  A. Mantovani,et al.  The signal transduction pathway involved in the migration induced by a monocyte chemotactic cytokine. , 1991, Journal of immunology.

[24]  B. Fenton,et al.  Alteration of tumour response to radiation by interleukin-2 gene transfer , 2000, British Journal of Cancer.

[25]  René Lefever,et al.  Stability problems in cancer growth and nucleation , 1980 .

[26]  Markus R. Owen,et al.  MATHEMATICAL MODELLING OF MACROPHAGE DYNAMICS IN TUMOURS , 1999 .

[27]  R. Sutherland Cell and environment interactions in tumor microregions: the multicell spheroid model. , 1988, Science.

[28]  S. Rosenberg,et al.  Specific release of granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-alpha, and IFN-gamma by human tumor-infiltrating lymphocytes after autologous tumor stimulation. , 1991, Journal of immunology.

[29]  L. Holmberg,et al.  Work on your theories! , 1996, Nature Medicine.

[30]  J A Sherratt,et al.  Pattern formation and spatiotemporal irregularity in a model for macrophage-tumour interactions. , 1997, Journal of theoretical biology.

[31]  G. D. Knott,et al.  Modeling tumor regrowth and immunotherapy , 2001 .

[32]  M A Lewis,et al.  Ecological chaos in the wake of invasion. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[33]  E. Lord,et al.  Assessment of in situ host immunity to syngeneic tumors utilizing the multicellular spheroid model. , 1984, Cellular immunology.

[34]  R. D'Amato,et al.  Persistence of microscopic human cancers in mice: alterations in the angiogenic balance accompanies loss of tumor dormancy , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  R T Prehn,et al.  Stimulatory effects of immune reactions upon the growths of untransplanted tumors. , 1994, Cancer research.

[36]  M. Cross,et al.  Pattern formation outside of equilibrium , 1993 .

[37]  Z Bajzer,et al.  Analysis of growth of multicellular tumour spheroids by mathematical models , 1994, Cell proliferation.

[38]  D. Loeffler,et al.  In vivo localization of lymphocytes labelled with low concentrations of Hoechst 33342. , 1989, Journal of immunological methods.

[39]  G. Naumov,et al.  Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. , 2002, Cancer research.

[40]  A. Perelson,et al.  Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis. , 1994, Bulletin of mathematical biology.

[41]  S. Rosenberg,et al.  T-cell recognition of human melanoma antigens. , 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

[42]  G. Heppner,et al.  Mechanisms of lymphocyte traffic in neoplasia. , 1986, Anticancer research.

[43]  R. Puri,et al.  Kinetic analysis of high affinity forms of interleukin (IL)-13 receptors: suppression of IL-13 binding by IL-2 receptor gamma chain. , 1999, Biophysical journal.

[44]  J. Jääskeläinen,et al.  Migration of recombinant IL-2-activated T and natural killer cells in the intercellular space of human H-2 glioma spheroids in vitro. A study on adhesion molecules involved. , 1992, Journal of immunology.

[45]  C. T. Chan,et al.  Characterization of three-dimensional tissue cultures using electrical impedance spectroscopy. , 1999, Biophysical journal.

[46]  E. Lord,et al.  Specific (EMT6) and non-specific (WEHI-164) cytolytic activity by host cells infiltrating tumour spheroids. , 1987, British Journal of Cancer.

[47]  Mark A. J. Chaplain,et al.  On Growth and Form: Spatio-temporal Pattern Formation in Biology , 2000 .

[48]  T. Rothstein,et al.  Guinea pig antiserum to mouse cytotoxic T lymphocytes and their precursors. , 1978, Journal of immunology.

[49]  J. Uhr,et al.  Dormancy in a model of murine B cell lymphoma. , 2001, Seminars in cancer biology.

[50]  M. Bar‐eli Role of Interleukin-8 in Tumor Growth and Metastasis of Human Melanoma , 1999, Pathobiology.

[51]  Bard Ermentrout,et al.  Simulating, analyzing, and animating dynamical systems - a guide to XPPAUT for researchers and students , 2002, Software, environments, tools.

[52]  H. Macdonald,et al.  The multicellular spheroid as a model tumor allograft. III. Morphological and kinetic analysis of spheroid infiltration and destruction. , 1980, Transplantation.

[53]  K. Hicks,et al.  Multicellular membranes as an in vitro model for extravascular diffusion in tumours. , 1996, The British journal of cancer. Supplement.

[54]  R. Foà,et al.  Gene transfer in tumor therapy. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

[55]  R. Sutherland,et al.  Growth and cellular characteristics of multicell spheroids. , 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[56]  R. Kobayashi,et al.  Self-organized pulse generator , 1995 .

[57]  G. Nardella,et al.  The multicellular tumor spheroid model. II. Characterization of the primary allograft response in unsensitized mice. , 1980, Transplantation.

[58]  E. Bröcker,et al.  Inflammatory cell infiltrates in human melanoma at different stages of tumor progression , 1988, International journal of cancer.

[59]  J. Folkman,et al.  How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture. , 1986, Cancer research.

[60]  P. Newsholme,et al.  Macrophage-mediated lysis of a beta-cell line, tumour necrosis factor-alpha release from bacillus Calmette-Guérin (BCG)-activated murine macrophages and interleukin-8 release from human monocytes are dependent on extracellular glutamine concentration and glutamine metabolism. , 1999, Clinical science.

[61]  M. Chaplain,et al.  Spatio-temporal dynamics of the immune system response to cancer , 1997 .

[62]  R. Gatenby,et al.  Models of tumor-host interaction as competing populations: implications for tumor biology and treatment. , 1995, Journal of theoretical biology.

[63]  H. Nishiura,et al.  Human CC chemokine liver-expressed chemokine/CCL16 is a functional ligand for CCR1, CCR2 and CCR5, and constitutively expressed by hepatocytes. , 2001, International immunology.

[64]  J. Sherratt,et al.  Cells behaving badly: a theoretical model for the Fas/FasL system in tumour immunology. , 2002, Mathematical biosciences.

[65]  R. Weger,et al.  Immune reactivity in SL2 lymphoma-bearing mice compared with SL2-immunized mice , 2004, Cancer Immunology, Immunotherapy.

[66]  V. Schirrmacher T-cell immunity in the induction and maintenance of a tumour dormant state. , 2001, Seminars in cancer biology.

[67]  Rene Lefever,et al.  On the Growth of Cellular Tissues Under Constant and Fluctuating Environmental Conditions , 1984 .

[68]  J A Sherratt,et al.  Modelling the macrophage invasion of tumours: effects on growth and composition. , 1998, IMA journal of mathematics applied in medicine and biology.

[69]  S. Cox,et al.  Modelling Macrophage Infiltration into Avascular Tumours , 2002 .

[70]  R. Gatenby,et al.  Application of competition theory to tumour growth: implications for tumour biology and treatment. , 1996, European journal of cancer.

[71]  S. Cole,et al.  Uptake kinetics of monoclonal antibodies by human malignant melanoma multicell spheroids. , 1988, Cancer research.

[72]  P. Musiani,et al.  Tumor Rejection and Immune Memory Elicited by Locally Released LEC Chemokine Are Associated with an Impressive Recruitment of APCs, Lymphocytes, and Granulocytes1 , 2000, The Journal of Immunology.

[73]  K. Weinhold,et al.  The tumor dormant state. , 1981, Advances in cancer research.

[74]  W. Clark,et al.  The biologic forms of malignant melanoma. , 1986, Human pathology.